vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $95.2M, roughly 1.8× Black Stone Minerals, L.P.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -8.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -9.7%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
BSM vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $168.4M |
| Net Profit | $72.2M | — |
| Gross Margin | — | — |
| Operating Margin | 78.6% | 50.6% |
| Net Margin | 75.9% | — |
| Revenue YoY | -8.7% | 143.7% |
| Net Profit YoY | 55.8% | — |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | $168.4M | ||
| Q3 25 | $105.2M | $87.3M | ||
| Q2 25 | $106.7M | $82.4M | ||
| Q1 25 | $115.3M | $65.0M | ||
| Q4 24 | $104.3M | $69.1M | ||
| Q3 24 | $103.2M | $51.6M | ||
| Q2 24 | $115.2M | $73.8M | ||
| Q1 24 | $116.8M | $137.7M |
| Q4 25 | $72.2M | — | ||
| Q3 25 | $91.7M | $-31.3M | ||
| Q2 25 | $120.0M | $-12.7M | ||
| Q1 25 | $15.9M | $-40.5M | ||
| Q4 24 | $46.3M | — | ||
| Q3 24 | $92.7M | $-29.5M | ||
| Q2 24 | $68.3M | $-61.9M | ||
| Q1 24 | $63.9M | $61.0M |
| Q4 25 | 78.6% | 50.6% | ||
| Q3 25 | 89.5% | -11.4% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | 14.9% | -34.0% | ||
| Q4 24 | 45.6% | -6.4% | ||
| Q3 24 | 90.2% | -31.0% | ||
| Q2 24 | 59.5% | 3.5% | ||
| Q1 24 | 54.8% | 52.5% |
| Q4 25 | 75.9% | — | ||
| Q3 25 | 87.2% | -35.9% | ||
| Q2 25 | 112.5% | -15.4% | ||
| Q1 25 | 13.8% | -62.2% | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 89.9% | -57.2% | ||
| Q2 24 | 59.3% | -83.9% | ||
| Q1 24 | 54.7% | 44.3% |
| Q4 25 | — | $0.32 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $167.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-302.0M |
| Total Assets | $1.3B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $167.9M | ||
| Q3 25 | $2.9M | $92.4M | ||
| Q2 25 | $2.5M | $86.1M | ||
| Q1 25 | $2.4M | $114.6M | ||
| Q4 24 | $2.5M | $144.8M | ||
| Q3 24 | $21.0M | $144.7M | ||
| Q2 24 | $26.7M | $189.3M | ||
| Q1 24 | $40.5M | $226.6M |
| Q4 25 | — | $-302.0M | ||
| Q3 25 | — | $-451.4M | ||
| Q2 25 | — | $-433.5M | ||
| Q1 25 | — | $-426.2M | ||
| Q4 24 | — | $-388.7M | ||
| Q3 24 | — | $-370.2M | ||
| Q2 24 | — | $-344.2M | ||
| Q1 24 | — | $-294.3M |
| Q4 25 | $1.3B | $465.9M | ||
| Q3 25 | $1.3B | $364.0M | ||
| Q2 25 | $1.3B | $347.1M | ||
| Q1 25 | $1.2B | $324.0M | ||
| Q4 24 | $1.2B | $343.8M | ||
| Q3 24 | $1.2B | $314.1M | ||
| Q2 24 | $1.2B | $352.3M | ||
| Q1 24 | $1.2B | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $45.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | $45.2M | ||
| Q3 25 | $99.8M | $-4.3M | ||
| Q2 25 | $80.5M | $-31.4M | ||
| Q1 25 | $64.8M | $-22.6M | ||
| Q4 24 | $91.0M | $-35.0M | ||
| Q3 24 | $93.2M | $-35.3M | ||
| Q2 24 | $100.4M | $-7.2M | ||
| Q1 24 | $104.5M | $53.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-35.5M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $53.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -68.7% | ||
| Q2 24 | — | -9.9% | ||
| Q1 24 | — | 39.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 4.07× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
